1756 Organometallics, Vol. 27, No. 8, 2008
SeVryugina et al.
1325(sh), 1279(s), 1188(m), 1155(sh), 1137(s), 1130(m), 915(m),
> 2σ(I) (R1 ) 0.0475, wR2 ) 0.1169 for 3796 unique reflections)
and a goodness of fit of 1.061. Final difference map is between
+1.870 and -1.474 e/Å3. For VIII full-matrix least-squares
refinement on F2 converged at R1 ) 0.0461 and wR2 ) 0.1003 for
433 parameters and 3548 reflections with I > 2σ(I) (R1 ) 0.0673,
wR2 ) 0.1095 for 4623 unique reflections) and a goodness of fit of
1.023. Final difference map is between +1.102 and -0.626 e/Å3.
For IX full-matrix least-squares refinement on F2 converged at R1
) 0.0441 and wR2 ) 0.1035 for 550 parameters and 5533 reflections
with I > 2σ(I) (R1 ) 0.0654, wR2 ) 0.1155 for 7438 unique
reflections) and a goodness of fit of 1.007. Final difference map is
between +1.024 and -0.711 e/Å3. For X full-matrix least-squares
refinement on F2 converged at R1 ) 0.0177 and wR2 ) 0.0444 for
261 parameters and 3376 reflections with I > 2σ(I) (R1 ) 0.0183,
wR2 ) 0.0449 for 3475 unique reflections) and a goodness of fit of
1.075. Final difference map is between +0.527 and -0.622 e/Å3.
Catalytic Reactions. Cyclopropanations. Reactions at 23 °C:
To a rigorously dried round flask was added the diruthenium(I,I)
catalyst (1 mol %) dissolved in CH2Cl2(1 mL). Styrene (0.25-0.3
mL, 2.1-2.6 mmol, 10 equiv) was added and the solution stirred
at room temperature for a few minutes under Ar to ensure complete
catalyst dissolution. Diazoacetate 7 (0.035 g, 0.2 mmol, 1 equiv)
was dissolved in CH2Cl2 (3 mL) and added to the reaction over
3 h via syringe pump, and the solution was then allowed to stir
overnight at room temperature. The mixture was then concentrated
in Vacuo. Reactions at 40 °C: To a rigorously dried round flask
was added the diruthenium(I,I) catalyst (1 mol %) dissolved in
CH2Cl2 (2 mL) under Ar atmosphere. Styrene (0.3 mL, 2.6 mmol,
13 equiv) was added, and the solution was heated to reflux. Methyl
phenyldiazoacetate 7 (0.035 g, 0.2 mmol, 1 equiv) was dissolved
in dry CH2Cl2 (3 mL) and added to the reaction mixture with a
syringe pump at the top of the reflux condenser over 3 h. The
solution was then allowed to stir for 2-5 h at reflux until all diazo
compound was decomposed (monitored by TLC). The mixture was
cooled to room temperature, concentrated in Vacuo, analyzed
by crude 1H NMR spectroscopy, and purified by flash column
chromatography (SiO2, 10% Et2O/pentane) to afford a white solid.
Data for Z-8: 1H NMR (400 MHz, CDCl3): δ 7.11-7.09 (m, 3H),
7.03-7.00 (m, 5H), 6.76-6.74 (m, 2H), 3.63 (s, 3H), 3.11 (dd,
1H, J ) 7.0, 9.5 Hz), 2.13 (dd, 1H, J ) 5.0, 9.5 Hz), 1.86 (dd, 1H,
J ) 5.0, 7.0 Hz). The spectroscopic data are consistent with the
previously reported results.35
1
847(m), 789(m), 768(m), 710(m), 682(m). H NMR ((CD3)2CO,
22 °C): δ 8.47, 8.22 (C-Harom) with an integrated ratio of 2:1. 19F
NMR (CDCl3, 22 °C): δ -62.41.
Preparation of [Ru2(O2C(3,5-CF3)2C6H3)2(CO)5 · (C6H5CH3)]
(IX). [Ru2(O2CCF3)2(CO)5] (I) (0.035 g, 0.06 mmol) was dissolved
in 10 mL of toluene. The yellow solution was filtered to a round-
bottom flask, which was then connected to a tube with a pre-
evacuated mineral oil. Orange crystals of IX appeared in 1 day in
80-90% yield.
Preparation of [Ru2(O2CCF3)2(CO)4 · (H2O)2] (X). [Ru2(O2-
CCF3)2(CO)4] (VII) (0.050 g, 0.09 mmol) was dissolved in 2 mL
of toluene, followed by the addition of several drops of water. The
red-colored solution was filtered to a clean round-bottom flask,
which was then connected to a tube with a pre-evacuated mineral
oil. Orange crystals of X appeared after 1 month in 80-90% yield.
X-ray Crystallographic Study. X-ray crystal data and refine-
ment details for IV: C38H8F12O18Ru4, fw ) 1384.72, yellow block,
0.23 × 0.06 × 0.05 mm, monoclinic P21/n, a ) 10.3336(5) Å, b
) 11.8386(6) Å, c ) 18.0531(10) Å, ꢀ ) 106.042(1)°, V )
2122.53(19) Å3, Z ) 2, Dc ) 2.167 g · cm-3, µ ) 1.527 mm-1, T
) 173(2) K, θmax ) 28.27°. For V: C38H8F12O18Ru4, fw ) 1384.72,
yellow block, 0.07 × 0.06 × 0.05 mm, monoclinic P21/n, a )
10.2883(5) Å, b ) 15.4363(8) Å, c ) 14.0317(7) Å, ꢀ )
110.340(1)°, V ) 2089.47(18) Å3, Z ) 2, Dc ) 2.201 g · cm-3, µ
) 1.551 mm-1, T ) 173(2) K, θmax ) 28.26°. For VI:
C38F20O18Ru4, fw ) 1528.66, yellow block, 0.10 × 0.09 × 0.08
mm, triclinic P1, a ) 9.6158(10) Å, b ) 10.5643(11) Å, c )
11.7591(12) Å, R ) 112.876(1)°, ꢀ ) 95.196(2)°, γ ) 91.192(2)°,
V ) 1094.0(2) Å3, Z ) 1, Dc ) 2.320 g · cm-3, µ ) 1.518 mm-1
,
T ) 173(2) K, θmax ) 25.00°. For VIII: C22H6F12O8Ru2, fw )
828.41, orange needle, 0.13 × 0.05 × 0.02 mm, triclinic P1, a )
9.6393(7) Å, b ) 11.3055(8) Å, c ) 14.1228(10) Å, R )
72.102(1)°, ꢀ ) 73.861(1)°, γ ) 67.004(1)°, V ) 1326.11(16) Å3,
Z ) 2, Dc ) 2.075 g · cm-3, µ ) 1.269 mm-1, T ) 173(2) K, θmax
) 24.99°. For IX: C30H14F12O9Ru2, fw ) 948.55, orange plate,
0.11 × 0.08 × 0.04 mm, triclinic P1, a ) 11.5905(7) Å, b )
11.9241(7) Å, c ) 13.0024(8) Å, R ) 76.263(1)°, ꢀ ) 73.727(1)°,
γ ) 77.817(1)°, V ) 1655.44(17) Å3, Z ) 2, Dc ) 1.903 g · cm-3
,
µ ) 1.032 mm-1, T ) 173(2) K, θmax ) 28.15°. For X:
C8H4F6O10Ru2, fw ) 576.25, orange block, 0.25 × 0.10 × 0.07
mm, monoclinic P21/c, a ) 12.6491(5) Å, b ) 8.7326(3) Å, c )
13.6260(5) Å, ꢀ ) 99.274(1)°, V ) 1485.45(9) Å3, Z ) 4, Dc )
2.577 g · cm-3, µ ) 2.157 mm-1, T ) 173(2) K, θmax ) 28.28°.
Bruker SMART APEX CCD-based X-ray diffractometer system,
Mo KR radiation (λ ) 0.71073 Å). Data were corrected for
absorption effects using the empirical methods SADABS (minimum/
maximum apparent transmissions are 0.7203/0.9276, 0.8992/0.9265,
0.8630/0.8882, 0.8524/0.9751, 0.8949/0.9599, and 0.6147/0.8637
for IV, V, VI, VIII, IX, and X, respectively). All non-hydrogen
atoms were refined anisotropically, except for disordered carbon
and fluorine atoms of four CF3 groups in VIII, three CF3 groups
in IX, and one CF3 group in X, for which disorder was modeled
over three rotational orientations. Hydrogen atoms in IV-VI and
X were found in the difference Fourier map and refined indepen-
dently, while their refinement in VIII and IX was mixed. For IV
full-matrix least-squares refinement on F2 converged at R1 ) 0.0207
and wR2 ) 0.0502 for 341 parameters and 4770 reflections with I
> 2σ(I) (R1 ) 0.0221, wR2 ) 0.0507 for 4997 unique reflections)
and a goodness of fit of 1.111. Final difference map is between
+0.430 and -0.542 e/Å3. For V full-matrix least-squares refinement
on F2 converged at R1 ) 0.0219 and wR2 ) 0.0532 for 341
parameters and 4455 reflections with I > 2σ(I) (R1 ) 0.0254, wR2
) 0.0546 for 4920 unique reflections) and a goodness of fit of 1.048.
Final difference map is between +0.489 and -0.349 e/Å3. For VI
full-matrix least-squares refinement on F2 converged at R1 ) 0.0438
and wR2 ) 0.1130 for 361 parameters and 3410 reflections with I
O-H Insertions. The diruthenium catalyst (0.007 g, 0.004
mmol, 1 mol %) was added to a rigorously dried round-bottom
flask purged with Ar. Anhydrous methanol (1 mL) was added to
dissolve the catalyst. Methyl phenylvinyldiazoacetate 4 (0.4 mmol,
1 equiv) was dissolved in anhydrous methanol (3 mL) and added
to the reaction mixture over 3 h via syringe pump. The reaction
mixture was allowed to stir at room temperature under argon for
24 h, concentrated in Vacuo, and then analyzed by crude 1H NMR
spectroscopy. Purification by flash column chromatography (SiO2,
10% Et2O/petroleum ether to 50% diethylether/petroleum ether
gradient) resulted in a colorless oil. Reaction with I with 0.2 mmol
of 4: Z-6:E-6:5a:5b ) 75:11:14:0 (0.022 g, 0.109 mmol, 45% yield);
reaction with II: Z-6:E-6:5a:5b ) 67:15:18:0 (0.022 g, 0.107 mmol,
26% yield); reaction with III: Z-6:E-6:5a:5b ) 62:18:20:0 (0.027
g, 0.132 mmol, 28% yield). Data for Z-6: 1H NMR (500 MHz,
CDCl3): δ 7.47-7.28 (m, 5H), 6.32 (dd, J ) 11.5, 9 Hz, 1H), 5.97
(d, J ) 9 Hz, 1H), 5.87 (d, J ) 11.5 Hz, 1H), 3.75 (s, 3H), 3.34 (s,
1
3H). Data for E-6: HNMR (500 MHz, CDCl3): δ 7.44-7.29 (m,
5H), 6.97 (dd, J ) 6, 15.5 Hz, 1H), 6.10 (d, J ) 15.5 Hz, 1H),
4.78 (d, J ) 6 Hz, 1H), 3.72 (s, 3H), 3.33 (s, 3H). Data for 5a,b:
1H NMR (500 MHz, CDCl3): δ 7.41-7.28 (m, 5H), 6.77 (d, J )
15.5, 1H), 6.20 (dd, J ) 7, 15.5, 1H), 4.43 (d, J ) 7, 1H), 3.79 (s,
(35) Thompson, J. L.; Davies, H. M. L. J. Am. Chem. Soc. 2007, 129,
6090–6091.